Brief Title
Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy
Official Title
Clinical Study of the Sensitivity and Specificity of the Quantitative Assessment of Bone Marrow Cellularity by MRI in Comparison With Trepanobiopsies in Patients With Diseases of the Hematopoietic System
Brief Summary
The study is aimed to find correlation between the assessment of cellularity according to trepanobiopsy data and the results of measuring MRI parameters.
Detailed Description
The ratio of fat to water in the bone marrow depends on the cellularity of the bone marrow. In addition to the water/fat ratio in bone marrow there are also other parameters for quantitative MRI assessment. These include the apparent diffusion coefficient (ACD), the T1 relaxation time, mapping of the macromolecular proton fraction. The undoubted advantage of MRI is its non-invasiveness and the ability to assess any localization of the bone marrow. MRI may become a new non-invasive method for assessing the cellularity of the bone marrow in children with oncohematological diseases.
Study Type
Interventional
Primary Outcome
correlation between Bone marrow cellularity by mDixon-quant and trepanobiopsy.
Secondary Outcome
T1 maping
Condition
Aplastic Anemia
Intervention
Bone marrow cellularity by mDixon-quant
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Diagnostic Test
Estimated Enrollment
150
Start Date
February 16, 2021
Completion Date
January 1, 2024
Primary Completion Date
December 26, 2023
Eligibility Criteria
Inclusion Criteria: presence of indications for performing trepanobiopsy: 1. aplastic anemia 2. chronic myeloproliferative disease 3. reactive changes in hematopoiesis Exclusion Criteria: 1. Refusal to sign an informed consent to participate in a clinical trial 2. Presence of contraindications for MRI examination 3. Extremely serious condition of the patient at the time of inclusion in the study.
Gender
All
Ages
6 Years - 18 Years
Accepts Healthy Volunteers
No
Contacts
, +7 (495)2876570, [email protected]
Location Countries
Russian Federation
Location Countries
Russian Federation
Administrative Informations
NCT ID
NCT04761965
Organization ID
NCPHOI-2019-06
Responsible Party
Sponsor
Study Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Study Sponsor
, ,
Verification Date
March 2023